Concurrent pembrolizumab with AVD for untreated classical Hodgkin lymphoma. Lynch RC, Ujjani CS, Poh C, Warren EH, et al. Blood 2023 Mar 13:blood.2022019254. doi: 10.1182/blood.2022019254.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lynch RC, Ujjani CS, Poh C, Warren EH, et al. Concurrent pembrolizumab with AVD for untreated classical Hodgkin lymphoma. Blood 2023 Mar 13:blood.2022019254. doi: 10.1182/blood.2022019254.
PMID: 36913694